1.Undifferentiated Adenocarcinoma with Rhabdoid Features in the Stomach: A Case Report.
Myoung Goo IM ; Kyong Hwa JUN ; Yong Sung WON ; Ji Han JUNG ; Hyung Min CHIN ; Woo Bae PARK ; Chung Soo CHUN
Journal of the Korean Gastric Cancer Association 2007;7(2):107-112
Rhabdoid tumor has been considered to be a rare subtype of Wilm's tumor with Rhabdomyoma features. Since rhabdoid tumor that developed in the kidney was described for the first time in 1989, it has been reported in the gastrointestinal tract, although this is rare. The appropriate treatment is radical resection, and the effect of adjuvant chemotherapy has not yet been reported on. The outcome of extra-renal rhabdoid tumor is different from renal rhabdoid tumor and the former shows a poor prognosis. Among extra-renal rhabdoid tumors, undifferentiated gastric adenocarcinoma with rhabdoid features is very rare and its prognosis is poor. A 63 years old male patient underwent total gastrectomy for a tumor that developed in the greater curvature of the gastric body and this was diagnosed as undifferentiated gastric adenocarcinoma with rhabdoid features, according to the histopathology. We experienced an undifferentiated gastric adenocarcinoma with rhabdoid features that was diagnosed by immunohistochemical staining and we report here on this case.
Adenocarcinoma*
;
Chemotherapy, Adjuvant
;
Gastrectomy
;
Gastrointestinal Tract
;
Humans
;
Kidney
;
Male
;
Middle Aged
;
Prognosis
;
Rhabdoid Tumor
;
Rhabdomyoma
;
Stomach Neoplasms
;
Stomach*
;
Wilms Tumor
2.Operative Treatment of Gastric Carcinoid Tumor Presenting as Multiple Polyps: A Case Report.
Sang Hyun AHN ; Jong Won KIM ; In Kyu LEE ; Hyuk Joon LEE ; Woo Ho KIM ; Kuhn Uk LEE ; Han Kwang YANG
Journal of the Korean Gastric Cancer Association 2007;7(2):102-106
Gastric carcinoid tumor is a neoplasm that arises from enterochromaffine-like (ECL) cells in the gastric fundus. It is a rare disease that comprises less than 2% of all gastric neoplasms; however its incidence has been recently increasing. We experienced one case of gastric carcinoid tumor that was revealed to be multiple polypoid lesions. A 29-year-old female patient visited a hospital three years ago due to syncope. The blood hemoglobin was measured as 6.0 g/dl. Gastroscopy revealed multiple polypoid lesions with bleeding; therefore endoscopic clipping was performed. The polyps were diagnosed as carcinoid tumor via endoscopic biopsy. She was transferred to our hospital because of persistent iron deficiency anemia that was caused by bleeding at the gastric polyps. Gastroscopy revealed more than twenty various-sized polypoid lesions from the mid-body to the antrum. The blood hemoglobin level was 9.0g/dl. Total gastrectomy was performed under the diagnosis of gastric carcinoid tumor with bleeding. All of the gastric polyps were diagnosed as carcinoid tumors, and any metastasis to the regional lymph nodes was not found. Eighteen months after operation, the blood hemoglobin was increased to 12.8g/dl with no evidence of recurrence. Surgical resection should be considered for treating gastric carcinoid tumor with continuous bleeding.
Adult
;
Anemia
;
Anemia, Iron-Deficiency
;
Biopsy
;
Carcinoid Tumor*
;
Diagnosis
;
Female
;
Gastrectomy
;
Gastric Fundus
;
Gastroscopy
;
Hemorrhage
;
Humans
;
Incidence
;
Lymph Nodes
;
Neoplasm Metastasis
;
Polyps*
;
Rare Diseases
;
Recurrence
;
Stomach Neoplasms
;
Syncope
3.Laparoscopy-assisted Total Gastrectomy with Pancreas-preserving Splenectomy for Early Gastric Cancer: A Case Report.
Jong Min PARK ; Do Yoon KIM ; Jae Man LEE ; Chai Sun LEEM ; Sung Ho JIN ; Yong Kwan CHO ; Sang Uk HAN
Journal of the Korean Gastric Cancer Association 2007;7(2):97-101
We report our experience with a case of performing laparoscopy-assisted total gastrectomy along with pancreas-preserving splenectomy for treating early gastric cancer. Laparoscopy-assisted total gastrectomy was planned for a 62-year-old male patient with a double early gastric cancer located in the upper and lower third of the stomach. Five trocars were placed and we used a harmonic scalpel to dissect the greater curvature. Enlarged splenic hilar lymph node was encountered and they were proved to be metastasis by frozen section biopsy. We then performed total gastrectomy with pancreas-preserving splenectomy for the purpose of completely dissecting the lymph nodes along the splenic artery and splenic hilum. We created a 4 cm sized longitudinal mini-laparotomy below the xiphoid process to remove the specimen, and anastomosis was done via the Roux-en-Y method. The patient was discharged on the 9th postoperative days after an uneventful recovery. Our experience shows that laparoscopy-assisted total gastrectomy with pancreas-preserving splenectomy is a relatively safe procedure for treating upper third early gastric cancer with metastatic splenic hilar lymph nodes.
Biopsy
;
Frozen Sections
;
Gastrectomy*
;
Humans
;
Lymph Nodes
;
Male
;
Middle Aged
;
Neoplasm Metastasis
;
Splenectomy*
;
Splenic Artery
;
Stomach
;
Stomach Neoplasms*
;
Surgical Instruments
4.Comparison of Reconstruction Methods after Distal Gastrectomy for Gastric Carcinoma in Terms of the Long Term Physiologic Function and Nutritional Status; Billroth I Gastroduodenostomy versus Roux-en Y Gastrojejunostomy.
Oh JEONG ; Sung Tae OH ; Jung Hwan YUK ; Ji Eun CHOI ; Kab Jung KIM ; Jung Taek LIM ; Gun Chun PARK ; Byung Sik KIM
Journal of the Korean Gastric Cancer Association 2007;7(2):88-96
PURPOSE: The only curative treatment for gastric carcinoma is surgery and it is still under debate which reconstruction method is better after performing gastrectomy for gastric carcinoma. The typical reconstruction methods after distal gastrectomy are Billroth I, Billroth II and Roux-en Y reconstruction. Yet it is difficult to compare these methods and not so much is known about which reconstruction is better in terms of the physiologic and nutritional function. With this background, we compared two reconstruction methods after distal gastrectomy (Billroth I versus Roux-en Y reconstruction) in terms of the long term physiologic function and nutritional status to create a reference for selecting reconstruction methods after distal gastrectomy. MATERIALS AND METHODS: Between 1999 and 2002, 663 patients who underwent distal gastrectomy for early gastric carcinoma filled out questionnaires every six months after operation, and these questionnaires evaluated the physiologic function. To evaluate their nutritional status, blood tests were performed every six months to check their albumin, protein and hemoglobin levels, and we checked the body weight every 6 months as well. RESULTS: The total score of the 15 questions on the questionnaire concerned with the physiologic function showed no difference between the two groups at every evaluation time, and both groups showed very low total scores, indicating tolerable physiologic function after operation. When comparing each question between two the groups, only symptoms of regurgitation and food passage showed a difference between the two groups, showing that the Roux-en Y group had better function in terms of these two symptoms. The Billroth I group showed a better nutrition status, indicating that the level of albumin, protein and hemoglobin were higher in the Billroth I group, with statistical significance. Body weight loss was severe in the Roux-en Y group. CONCLUSION: The physiologic function is slightly better in the Roux-en Y group in terms of some symptoms such as regurgitation and food passage. However, the nutritional status is better in the Billroth I group. In conclusion, because we cannot definitely ascertain which reconstruction is better when we consider both the physiologic and nutritional functions, it is reasonable that surgeon should choose reconstruction methods according to their experience and preference.
Body Weight
;
Gastrectomy*
;
Gastric Bypass*
;
Gastroenterostomy*
;
Hematologic Tests
;
Humans
;
Nutritional Status*
;
Surveys and Questionnaires
5.A Comparative Study of Stenting versus Surgical Bypass in Gastric Outlet Obstruction Caused by Gastric Cancer.
Seung Jin JO ; Ki Young YOON ; Kyung Hyun CHOI ; Moo In PARK ; Seun Ja PARK ; Ji Ho KO ; Sang Ho LEE
Journal of the Korean Gastric Cancer Association 2007;7(2):82-87
PURPOSE: In gastric cancer patients with gastric outlet obstruction, there are several complications such as malnutrition and vomiting. Palliative enteral stenting is a less invasive procedure as compared with a gastrojejunostomy. The aim of this study was to determine whether there was a significant difference between patients that undergone palliative enteral stenting and patients that had received a bypass gastrojejunostomy. MATERIALS AND METHODS: One hundred patients underwent palliative entering stenting and 31 patients were subjected to a surgical bypass gastrojejunostomy. We reviewed the medical records of the patients with gastric outlet obstruction secondary to far advanced gastric cancer that were diagnosed using a gastrofibroscope, UGI and abdominal CT, and were admitted to our institution between January 2000 and August 2006. The outcome of stent placement for gastric outlet obstruction was compared with palliative gastrojejunostomy during the same period. We excluded patients with recurrent gastric cancer and double cancer from this study. RESULTS: There were significant differences between the group of patients that underwent stenting and the group of patients that received a gastrojejunostomy regarding the age of patients (67+/-12 vs. 57+/-9, P<0.001) but not between the sex of the patients (M : F, 2 : 1 vs. 2 : 1, P=0.637). The most common complication of stenting was tumor ingrowth (16/100, 16%) and the second most common complication was stent migration (14/100). Failure of the procedure occurred in only three patients. Twenty-three patients underwent re-stenting and one patient required open conversion with a gastrojejunostomy. The median time to the first meal was 4+/-2 days in the stent group of patients and 6+/-2 days in the gastrojejunostomy group of patients (P=0.001). The median postoperative hospital stays were 9 days in the stent group of patients and 15 days in the gastrojejunostomy group of patients (P=0.003). The mean survival periods were 11 months in the stent group of patients and 10 months in the gastrojejunostomy group of patients (P=0.937). CONCLUSION: There were no significant differences in the mean survival rates. An earlier first meal and a shorter hospitalization stay were found in the stenting group of patients compared to the bypass gastrojejunostomy group of patients. However, re-stenting was a concern due to tumor ingrowth and stent migration.
Gastric Bypass
;
Gastric Outlet Obstruction*
;
Hospitalization
;
Humans
;
Length of Stay
;
Malnutrition
;
Meals
;
Medical Records
;
Stents*
;
Stomach Neoplasms*
;
Survival Rate
;
Tomography, X-Ray Computed
;
Vomiting
6.Total Gastrectomy with Distal Pancreatico-splenectomy for Treating Locally Advanced Gastric Cancer.
Sung Ho LEE ; Wook KIM ; Kyo Young SONG ; Jin Jo KIM ; Hyung Min CHIN ; Jo Hyun PARK ; Hae Myung JEON ; Seung Man PARK ; Chang Jun AHN ; Jun Hyun LEE
Journal of the Korean Gastric Cancer Association 2007;7(2):74-81
PURPOSE: Routine pancreatico-splenectomy with total gastrectomy should no longer be considered as the standard surgical procedure for gastric cancer because of the lack of proven surgical benefit for survival. The aim of this study is to evaluate the clinicopathologic factors and the survival of patients with locally advanced gastric cancer and they had undergone combined pancreatico-splenectomy with a curative intent. Material and Methods: We retrospectively reviewed a total of 118 patients who had undergone total gastrectomy with distal pancreatico-splenectomy from 1990 to 2001. The patients were divided into 2 groups: 90 patients who were free from cancer invasion (group I), and 28 patients with histologically proven cancer invasion into the pancreas (group II). The various clinicopathologic factors that were presumed to influence survival and the survival rates were analyzed. RESULTS: The rate of pathological pancreatic invasion was 23.7%. The tumor stage, depth of invasion, pancreas invasion, lymph node metastasis, lymph node ratio, curability and the hepatic and peritoneal metastasis were statistically significance on univariate analysis. Among these factors, the tumor stage, lymph node ratio and curability were found to be independent prognostic factor on multivariate analysis. The 5-years survival rates were 36.2% for group I and 13.9% for group II. The morbidity rate was 22.1%, and this included pancreatic fistula (5.1%), intra-abdominal abscess (4.2%) and bleeding (4.2%). The overall mortality rate was 6.8%. CONCLUSION: Combined distal pancreatico-splenectomy with total gastrectomy with a curative intent was selectively indicated for those patients with visible tumor invasion to the pancreas, a difficult complete lymph node dissection around the distal pancreas and spleen, and no evidence of liver metastasis or peritoneal dissemination.
Abdominal Abscess
;
Gastrectomy*
;
Hemorrhage
;
Humans
;
Liver
;
Lymph Node Excision
;
Lymph Nodes
;
Mortality
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Pancreas
;
Pancreatic Fistula
;
Retrospective Studies
;
Spleen
;
Stomach Neoplasms*
;
Survival Rate
7.Clinicopathologic Characteristics and the Prognosis of Gastric Cancer Patients at Both Extremes of Age.
Rack Jong SONG ; Sun Pil KIM ; Young Don MIN
Journal of the Korean Gastric Cancer Association 2007;7(2):67-73
PURPOSE: There have been several comparative studies that have focused on elderly groups of patients with gastric cancer. However, new criteria are needed for this elderly group because of the longer life span of Korean people. The diagnosis of gastric cancer has sometimes been missed in the young age group. The perioperative risk is high in the elderly age group because of their combined diseases. This study was designed to determine the differences of the clinicopathologic features and the prognosis between young and elderly patients with gastric cancer. MATERIALS AND METHODS: Eighty patients were divided in two groups and these patients were selected for making comparison between young and elderly groups of patients with gastric cancer. The young age group consisted of 31 patients who were aged 35 years old or less. The elderly age group was made up of 49 patients who were aged 75 years old or above. RESULTS: For the clinicopathologic features, the young age group was characterized by a high incidence of the poorly differentiated type of adenocarcinoma and the diffuse type too, according to the Lauren classification. On the other hand, the elderly group was characterized by a high incidence of poorly to moderate differentiated adenocarcinoma and also the intestinal type according to the Lauren classification. The other clinical differences were unremarkable. Additionally, there was no survival advantage in the young age group compared to the elderly group. CONCLUSION: There were no clinicopathologic and prognostic differences between both extreme age groups. So, active surgical treatment is recommended even for the elderly patients group.
Adenocarcinoma
;
Adult
;
Aged
;
Classification
;
Diagnosis
;
Hand
;
Humans
;
Incidence
;
Prognosis*
;
Stomach Neoplasms*
8.Multiple Genetic Marker Analysis wih Using Quantitative RT-PCR in Gastric Cancer.
Moon Won YOO ; Hyuk Joon LEE ; Soo Min CHOI ; Jieun YU ; Keun HUR ; Young Kook KIM ; Han Kwang YANG
Journal of the Korean Gastric Cancer Association 2007;7(2):59-66
PURPOSE: This study was aimed at evaluating the diagnostic validity of peritoneal dissemination of gastric cancer cells by performing multiple genetic marker analysis via quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in gastric cancer cell lines and gastric cancer tissues. MATERIALS AND METHODS: Quantitative RT-PCR was performed on 12 human gastric cancer cell lines and 10 gastric cancer tissues with four mRNAs of carcinoembryonic antigen (CEA), Cytokeratin 20 (CK20), dopa decarboxylase (DDC), and L-3-phosphoserine phosphatase (L3PP). RESULTS: Out of the 12 human gastric cancer cell lines we tested, CEA was overexpressed in four cell lines (33%), CK20 in one (8%), DDC in six (50%) and L3PP was expessed in all the lines (100%). Out of the 10 gastric cancer tissues we tested, CEA was overexpressed in nine tissues, CK20 in eight, DDC in nine and L3PP was overexpressed in all the tissues. L3PP was overexpressed in all the gastric cancer cell lines and tissues, but the levels of overexpression were lower than those of CEA and DDC. CONCLUSION: Multiple genetic marker analysis can compensate for the weak points of single marker analysis when testing gastric cancer, and three mRNAs of CEA, DDC and L3PP can be used as candidate genes.
Carcinoembryonic Antigen
;
Cell Line
;
Dopa Decarboxylase
;
Genetic Markers*
;
Humans
;
Keratin-20
;
RNA, Messenger
;
Stomach Neoplasms*
9.Immunohistochemical Analysis of Phosphorylated Akt Protein Expression in Gastric Carcinomas.
Sug Hyung LEE ; Jong Woo LEE ; Won Sang PARK ; Jung Young LEE ; Nam Jin YOO ; Su Young KIM
Journal of the Korean Gastric Cancer Association 2003;3(2):88-92
PURPOSE: Mounting evidence suggests that alterations of Akt/protein kinase B (PKB) play an important role in tumorigenesis. Phosphorylated Akt regulates many of the key effector molecules involved in apoptosis, angiogenesis, and cell-cycle progression during tumorigenesis. The expression of phosphorylated Akt has been described in some human malignancies, but not in primary human gastric cancer. The purpose of this study was to explore the expression status of phosphorylated Akt protein in gastric carcinomas. MATERIALS AND METHODS: In the current study, we analyzed the expression of phosphorylated Akt protein in 60 advanced gastric adenocarcinomas by using immunohistochemistry and a tissue microarray approach. RESULTS: Immunopositivity (defined as > or =30%) was observed for the phosphorylated Akt in 42 (70%) of the 60 cancers. Normal gastric mucosal cells showed no or weak expression of phosphorylated Akt protein. CONCLUSION: Taken together, these results indicate that Akt is frequently activated in gastric adenocarcinoma cells and suggest that phosphorylayed Akt may play a role in the development of human gastric adenocarcinomas.
Adenocarcinoma
;
Apoptosis
;
Carcinogenesis
;
Humans
;
Immunohistochemistry
;
Phosphotransferases
;
Stomach Neoplasms
10.Mutational Analysis of Proapoptotic Bcl-2 Family Members in Gastric Carcinomas.
Nam Jin YOO ; Jong Woo LEE ; Young Hwa SOUNG ; Hong Sug KIM ; Won Sang PARK ; Jung Young LEE ; Sug Hyung LEE
Journal of the Korean Gastric Cancer Association 2003;3(2):84-87
PURPOSE: Evidence exists that dysregulation of Bcl-2 family members is involved in the pathogenesis of cancer development. The aim of this study was to explore whether the somatic mutation of proapoptotic Bcl-2 member genes, one of the mechanisms that prolong the survival of cancer cells, is involved in gastric carcinogenesis. MATERIALS AND METHODS: In the current study, to detect somatic mutations of the DNA sequences encoding the Bcl-2 homology 3 (BH3) domain of the human BAD, BIM, BIK, and Bcl-G genes in 60 advanced gastric adenocarcinomas, we used the polymerase chain reaction (PCR), single strand conformation polymorphism (SSCP), and DNA sequencing. RESULTS: The SSCP analysis revealed no mutations in the coding regions of the BH3 domain in the cancers. CONCLUSION: The data presented here indicate that proapoptotic Bcl-2 member genes, BAD, BIM, BIK, and Bcl-G, may not be mutated in human gastric carcinomas and suggest that these genes might be altered by mechanisms other mechanisms somatic mutation.
Adenocarcinoma
;
Apoptosis
;
Base Sequence
;
Carcinogenesis
;
Clinical Coding
;
Humans
;
Polymerase Chain Reaction
;
Polymorphism, Single-Stranded Conformational
;
Sequence Analysis, DNA